Medicine. New TB drug promises shorter, simpler treatment.
Cohen
Jon
J
D000255:Adenosine Triphosphate / Q000096:biosynthesis; D000818:Animals; D000995:Antitubercular Agents / Q000493:pharmacokinetics / Q000494:pharmacology / Q000627:therapeutic use*; D002986:Clinical Trials as Topic; D064687:Diarylquinolines; D024881:Drug Resistance, Bacterial; D004359:Drug Therapy, Combination; D006801:Humans; D051379:Mice; D020102:Mycobacterium smegmatis / Q000187:drug effects / Q000201:enzymology / Q000235:genetics; D009169:Mycobacterium tuberculosis / Q000187:drug effects* / Q000201:enzymology / Q000235:genetics; D011804:Quinolines / Q000493:pharmacokinetics / Q000494:pharmacology / Q000627:therapeutic use*; D014376:Tuberculosis / Q000188:drug therapy* / Q000382:microbiology
D000995:Antitubercular Agents; D064687:Diarylquinolines; D011804:Quinolines; C493870:bedaquiline; D000255:Adenosine Triphosphate